Health Care & Life Sciences » Biotechnology | Oxford Immunotec Global PLC

Oxford Immunotec Global PLC | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
8,664.00
22,174.00
24,478.00
22,349.00
32,885.00
12,505
Depreciation, Depletion & Amortization
1,101.00
1,742.00
2,142.00
3,094.00
4,240.00
1,662
Other Funds
-
-
-
-
212.00
7,909
Funds from Operations
6,584.00
17,889.00
18,197.00
13,679.00
5,480.00
16,684
Changes in Working Capital
965.00
2,888.00
1,648.00
8,242.00
1,894.00
15,435
Net Operating Cash Flow
5,619.00
20,777.00
16,549.00
21,921.00
3,586.00
32,119
Capital Expenditures
2,014.00
3,368.00
3,468.00
2,383.00
5,029.00
Sale of Fixed Assets & Businesses
22.00
-
34.00
-
-
Purchase/Sale of Investments
-
-
312.00
120.00
-
Net Investing Cash Flow
1,767.00
5,027.00
3,122.00
30,018.00
5,029.00
Issuance/Reduction of Debt, Net
3,856.00
165.00
122.00
29,038.00
261.00
Net Financing Cash Flow
70,699.00
151.00
53,657.00
29,114.00
39,386.00
Net Change in Cash
63,916.00
26,329.00
33,550.00
24,605.00
31,222.00
Free Cash Flow
7,428.00
23,791.00
19,974.00
24,304.00
8,615.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
1,602.00
38,760
Net Assets from Acquisitions
-
1,716.00
-
27,515.00
-
Other Sources
225.00
57.00
-
-
-
Change in Capital Stock
66,843.00
14.00
53,779.00
76.00
39,859.00
Exchange Rate Effect
603.00
374.00
436.00
1,780.00
451.00

About Oxford Immunotec Global

View Profile
Address
Milton Park
Abingdon Oxfordshire OX14 4RZ
United Kingdom
Employees -
Website http://oxfordimmunotec.com
Updated 07/08/2019
Oxford Immunotec Global Plc operates as a medical diagnostics company, which develops and commercializes proprietary tests for under-served immune-regulated conditions. Its current product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. Its products include T-SPOT.